Mechanism of covalent adduct formation of aucubin to proteins

Toxicology Letters

Volumn 114, Issue 1-3, 2000, Pages 181-188

  Kim, Dong Hyun ^a   Kim, Bok Ryang ^b   Kim, Ji Yeon ^a   Jeong, Yo Chan ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Won Kwang Iniv   (South Korea)

Author keywords

Aucubin; Covalent binding; Serum albumin

Indexed keywords

AUCUBIN; BETA GLUCOSIDASE; IMINE; IRIDOID; SERUM ALBUMIN; SODIUM CYANIDE; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; COVALENT BOND; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT;

ADMINISTRATION, ORAL; ANIMALS; BETA-GLUCOSIDASE; BLOOD PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSIDES; IMINES; INJECTIONS, INTRAVENOUS; IRIDOIDS; KIDNEY; LIVER; MALE; PROTEIN BINDING; PYRANS; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; SODIUM CYANIDE; TISSUE DISTRIBUTION; TRITIUM;

EID: 0034599389     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00295-7     Document Type: Article

References (25)

1. Bartholomaeus A., Ahokas J. Inhibition of P-450 by aucubin: is the biological activity of aucubin due to its glutaraldehyde-like aglycone? Toxicol. Lett. 80:1995;75-83.
2. Bernini R., Iavarone C., Trogolo C. 1-O-β-D-Glucopyranosyleucommiol, an iridoid glucoside from Aucuba japonica. Phytochemistry. 23:1984;1431-1433.
3. Bianco A., Iavarone C., Trogolo C. Structure of eucommiol, a new cyclopentenoid-tetraol from Eucommia ulmoides. Tetrahedron. 30:1974;4117-4121.
4. Birge R.B., Bartolone J.B., Hart S.G. et al. Acetaminophen hepatotoxicity: correspondence of selective protein arylation in human and mouse liver in vitro, in culture, and in vivo. Toxicol. Appl. Pharmacol. 105:1990;472-478.
5. Bobbit J. Taylor W.I., Battersby A.R. Cyclopentanoid Terpene Derivatives. 1969;3 Marcel Dekker, New York.
6. Boelsterli U.A. Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury. Drug Metab. Rev. 25:1993;395-451.
7. Chang I.M. Liver protective activities of aucubin derived from traditional oriental medicine. Res. Commun. Mol. Pathol. Pharmacol. 102:1998;189-204.
8. Chang I.M., Ryu J.C., Park Y.C., Yun H.S., Yang K.H. Protective activities of aucubin against carbon tetrachloride-induced liver damage in mice. Drug Chem. Toxicol. 6:1983;443-453.
9. Davini E., Iavarone C., Trogolo C., Aureli P., Pasolini B. The quantitative isolation and antimicrobial activity of the aglycone of aucubin. Phytochemistry. 25(10):1986;2420-2422.
10. Hyneck M.L., Smith P.C., Munafo A., McDonagh A.F., Benet L.Z. Disposition and irreversible plasma protein binding of tolmetin in human. Clin. Pharmacol. Ther. 44:1988;107-114.
11. Ioku K., Pongpiriyadacha Y., Konishi Y., Takei Y., Nakatani N., Terao J. Glucosidase activity in the rat small intestine toward quercetin monoglucosides. Biosci. Biotechnol. Biochem. 62:1998;1428-1431.
12. Ishiguro K., Yamaki M., Takagi S. Studies on iridoid related compounds. I. On the antimicrobial activity of aucubigenin and certain iridoid aglycones. Yakuguku Zassi. 102:1982;755-759.
13. Ishiguro K., Yamaki M., Takagi S. et al. Studies on iridoid related compounds. IV. Antitumor activity of irridoid aglycones. Chem. Pharm. Bull. 34(6):1985;2375-2379.
14. Kretz-Rommel A., Boelsterli U.A. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins: retention of the glucuronic acid moiety in the adduct. Drug Metab. Dispos. 22:1994;956-961.
15. Martin J.L., Reed G.F., Pohl L.R. Association of anti-58 kDa endoplasmic reticulum antibodies with halothane hepatitis. Biochem. Pharmacol. 46:1993;1247-1250.
16. McKey A.M. Hydrolysis of vicine and convicine from fababeans by microbial β-glucosidase enzymes. J. Appl. Bacteriol. 72:1992;475-478.
17. Mohammad-Ali A.K., Chan T.H., Thomas A.W., Jewett B., Strunz G.M. Spruce budworm (Choristoneura fumiferana) antifeedants 4. Synthesis of specionin and biological studies. Can. J. Chem. 72:1994;2137-2143.
18. Nakano H., Gregory J. 3rd Pyridoxine and pyridoxine-5′-β-D-glucoside exert different effects on tissue B-6 vitamers but similar effects on β-glucosidase activity in rats. J. Nutr. 125:1995;2751-2762.
19. Pailer M., Haschke-Hofmeister E. Inhaltsttoffe aus Plantago major. Planta Med. 17:1969;139-145.
20. Skipper P., Obiedzinski M., Tannebaum S., Miller D., Mitchum R., Kadlubar F. Identification of the major serum albumin adducts formed by 4-aminobiphenyl in vivo in rats. Cancer Res. 45:1985;5122-5127.
21. Smith P.C, McDonagh A.F, Benet L.Z. Irreversible binding of zomepirac to plasma protein in vitro and in vivo. J. Clin. Invest. 77:1986;934-939.
22. Spahn-Langguth H., Benet L.Z. Acylglucuronides revisited: is the glucuronidation process a toxification as well as a detoxicification mechanism? Drug Metab. Rev. 24:1992;5-47.
23. Xu Y.C., Bizuneh A., Walker C. Selective deprotection of alkyl esters using magnesium methoxide. Tetrahedron Lett. 37:1995;455-458.
24. Yamazaki M., Hirota K., Chiba K., Mohri T. Promotion of neuronal differentiation of PC12h cells by natural lignans and iridoids. Biol. Pharm. Bull. 17:1994;1604-1608.
25. Ziegler R., Ho B., Castagnoli N. Jr Traping of metabolically generated electrophilic species with cyanide ion: metabolism of metapyrilene. J. Med. Chem. 24:1981;1133-1138.